Investment firm H.I.G. Capital announced Dec. 7 that its subsidiary, BECO Holding Company — an independent provider of critical fire, life safety and security solutions — has acquired fellow ...
On Sept. 30, The National Hockey League’s Boston Bruins and New England-based Electric Supply Center announced a partnership that will make ESC the Bruins’ official electrical distributor for the 2023 ...
ONEIDA, Wis. (WBAY) - The Oneida Nation’s business committee is replacing the board of managers for the Oneida Engineering, Science, and Construction (ESC) group and replacing it with an interim board ...
LIMA — The board of the Allen County Educational Service Center called for a special meeting to investigate a complaint against a public employee at 5:30 p.m. Thursday, Dec. 4 in the ESC office, 1920 ...
The European Society of Cardiology (ESC) will host its first Digital & AI Summit in Berlin on 21-22 November, bringing together global experts in cardiology, technology, and healthcare. This two-day ...
SAN FRANCISCO--(BUSINESS WIRE)--Zebra Technologies Corporation (NASDAQ: ZBRA), a global leader in digitizing and automating workflows to deliver intelligent operations, today announced the company is ...
Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License. THE EUROPEAN Society of Cardiology (ESC) celebrated a landmark moment this year, marking ...
Guidelines have been published by the ESC regarding the management of cardiovascular disease in pregnant patients. The 2025 European Society of Cardiology (ESC) guidelines for the management of ...
The European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) have released updated recommendations on the management of dyslipidaemia. The guidance presented at the ESC 2025 ...
Earlier, less-invasive treatment is at the core of the latest iteration of the joint European Society of Cardiology/European Association for Cardio-Thoracic Surgery (ESC/EACTS) valvular heart disease ...
LATE-breaking results from ESC 2025 show that aficamten, a cardiac myosin inhibitor, significantly improves exercise capacity and symptoms compared with metoprolol in patients with symptomatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results